Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/28/2000US6151956 Oil deterioration sensor
11/28/2000US6151952 System for mass emission sampling of combustion products
11/28/2000CA2308259A1 Method for assaying the function of flaa1 and wbpm
11/28/2000CA2307357A1 Wbpp and method for assay of wbpp
11/28/2000CA2305716A1 Method for assay of wbpm
11/28/2000CA2121659C Sample processing method for mycobacteria
11/28/2000CA2091243C Recombinant acc synthase
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/27/2000CA2292258A1 Identification of compounds for modulating dimeric receptors
11/27/2000CA2273576A1 Three-dimensional quaternary structure of the insulin receptor
11/23/2000WO2000070541A1 Transformation of digital images
11/23/2000WO2000070527A1 Method for optimizing multivariate calibrations
11/23/2000WO2000070385A2 High-resolution video microscope for measuring extracted samples of particle suspensions, with impressed sample oscillation
11/23/2000WO2000070353A2 High throughput assay systems and methods
11/23/2000WO2000070352A1 Treating cancer
11/23/2000WO2000070351A2 Protein-protein interactions and methods for identifying them
11/23/2000WO2000070350A1 METHOD AND APPARATUS FOR RAPID MEASUREMENT OF HbA¿1c?
11/23/2000WO2000070349A1 Identifying material from a breast duct
11/23/2000WO2000070348A1 Methods for predicting and/or diagnosing the risk of gastric cancer
11/23/2000WO2000070347A1 Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
11/23/2000WO2000070346A1 Chromatography quantitative measurement device, chromatography quantitative measurement method, and chromatography test piece used therefor
11/23/2000WO2000070345A1 Reversible immobilization of ligands onto metal surfaces, their preparation and use in biochemical applications
11/23/2000WO2000070344A2 Method for increasing the efficiency of experimental fractionation in activity profiling of compound mixtures
11/23/2000WO2000070343A2 G-protein coupled receptor based biosensors and sense replication systems
11/23/2000WO2000070342A2 Optical system analysis of cells
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070340A2 Materials and methods relating to disease diagnosis
11/23/2000WO2000070339A1 Water sampling with analyte extraction and integration
11/23/2000WO2000070338A1 Board mounted sensor placement into a furnace duct
11/23/2000WO2000070329A1 Nucleic acid-based detection
11/23/2000WO2000070327A1 System for electrochemical quantitative analysis of analytes within a solid phase
11/23/2000WO2000070322A2 A-FORM OF CYTOPLASMIC DOMAIN OF nARIA (CRD-NEUREGULIN) AND USES THEREOF
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070098A1 Microarray-based subtractive hybridization
11/23/2000WO2000070097A2 Profile searching in nucleic acid sequences using the fast fourier transformation
11/23/2000WO2000070096A2 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
11/23/2000WO2000070094A1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070090A1 Process for high throughput dna methylation analysis
11/23/2000WO2000070088A2 Immobilization of unmodified biopolymers to acyl fluoride activated substrates
11/23/2000WO2000070086A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/23/2000WO2000070084A1 Preparation of stable liquid and dried synthetic prothrombin time reagents
11/23/2000WO2000070083A1 Assay for myelosuppression by farnesyl transferase inhibitors
11/23/2000WO2000070082A1 Cell assay, method and reagents
11/23/2000WO2000070081A1 Detection of viral stability
11/23/2000WO2000070079A1 High throughput assay for modulators of nuclear receptors
11/23/2000WO2000070078A2 Method and device for determining the concentration of organisms
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070073A1 Method for sequencing nucleic acid molecules
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070041A1 Mixed-bed solid phase and its use in the isolation of nucleic acids
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000070023A1 Novel fab fragment libraries and methods for their use
11/23/2000WO2000070021A2 Differentiated human embryoid cells and a method for producing them
11/23/2000WO2000070011A1 Apparatus and method of testing a biological fluid
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069908A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069899A1 Compositions of solvents and high concentrations of nucleic acid analogs
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069451A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000WO2000069450A1 Oncogene identification by transformation of rk3e cells and uses thereof
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069391A2 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000039581A3 Test system for detecting different markers, and production and use thereof
11/23/2000WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression
11/23/2000WO2000036910A9 Msh5 ablated mice and uses therefor
11/23/2000WO2000036412A9 Method for monitoring advanced separation and/or ion exchange processes
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000034506A3 Method of screening candidate compounds for susceptibility to oxidative metabolism
11/23/2000WO2000033072A3 Analyte test instrument having improved calibration and communication processes
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000029556A3 Identification of glycosphingolipids that promote hiv-1 entry into cells
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000027423A3 Methods and compositions for treating common cold symptoms
11/23/2000WO2000027365A9 Functionalized nanocrystals and their use in detection systems
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000018355A3 Use of purified invaplex from gram negative bacteria as a vaccine
11/23/2000WO2000017369A3 Alzheimer's disease secretase
1 ... 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 ... 3937